490 related articles for article (PubMed ID: 26564155)
21. Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.
Urushihara M; Nagai T; Kinoshita Y; Nishiyama S; Suga K; Ozaki N; Jamba A; Kondo S; Kobori H; Kagami S
Pediatr Nephrol; 2015 Jun; 30(6):975-82. PubMed ID: 25523477
[TBL] [Abstract][Full Text] [Related]
22. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
23. Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study.
Park S; Baek CH; Go H; Kim YH; Min SI; Ha J; Kim YC; Lee JP; Kim YS; Moon KC; Park SK; Lee H
BMC Nephrol; 2019 Sep; 20(1):354. PubMed ID: 31510954
[TBL] [Abstract][Full Text] [Related]
24. Effects of dual blockade of the renin-angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT-Hypertension).
Imai E; Haneda M; Yamasaki T; Kobayashi F; Harada A; Ito S; Chan JC; Makino H
Hypertens Res; 2013 Dec; 36(12):1051-9. PubMed ID: 24026038
[TBL] [Abstract][Full Text] [Related]
25. Renin-angiotensin system blockade in heart failure patients on long-term haemodialysis in Taiwan.
Tang CH; Chen TH; Wang CC; Hong CY; Huang KC; Sue YM
Eur J Heart Fail; 2013 Oct; 15(10):1194-202. PubMed ID: 23671265
[TBL] [Abstract][Full Text] [Related]
26. Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy.
Narita I; Goto S; Saito N; Song J; Omori K; Kondo D; Sakatsume M; Gejyo F
Kidney Int; 2003 Sep; 64(3):1050-8. PubMed ID: 12911556
[TBL] [Abstract][Full Text] [Related]
27. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
Tempelhof MW
South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
[No Abstract] [Full Text] [Related]
28. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
[TBL] [Abstract][Full Text] [Related]
29. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
Mizerska-Wasiak M; Małdyk J; Pańczyk-Tomaszewska M; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Miklaszewska M; Pietrzyk J; Pukajło-Marczyk ; Zwolińska D; Szczepańska M; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
Rauta V; Finne P; Fagerudd J; Rosenlöf K; Törnroth T; Grönhagen-Riska C
Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
[TBL] [Abstract][Full Text] [Related]
31. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
32. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J;
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218
[TBL] [Abstract][Full Text] [Related]
33. Treatment of IgA nephropathy.
Pozzi C
J Nephrol; 2016 Feb; 29(1):21-5. PubMed ID: 26577268
[TBL] [Abstract][Full Text] [Related]
34. The beneficial effects of renin-angiotensin system inhibitors (RASI) on IgA nephropathy with tubulointerstitial lesions categorized by Oxford classification.
Kamiyama T; Moriyama T; Kumon S; Karasawa K; Nitta K
Clin Exp Nephrol; 2019 Jun; 23(6):834-840. PubMed ID: 30796546
[TBL] [Abstract][Full Text] [Related]
35. Renin-angiotensin system blockers are associated with reduced mortality and heart failure hospitalization in patients paced for complete atrioventricular block.
Elder DH; Lang CC; Rekhraj S; Szwejkowski B; George J; Pringle SD; Struthers AD; Choy AM
Heart Rhythm; 2012 Apr; 9(4):505-10. PubMed ID: 22094075
[TBL] [Abstract][Full Text] [Related]
36. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study.
Voskamp PWM; Dekker FW; van Diepen M; Hoogeveen EK;
J Am Soc Hypertens; 2017 Oct; 11(10):635-643. PubMed ID: 28802945
[TBL] [Abstract][Full Text] [Related]
37. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
38. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy.
Ishii T; Kawamura T; Tsuboi N; Ogura M; Utsunomiya Y; Hosoya T
Contrib Nephrol; 2007; 157():114-9. PubMed ID: 17495447
[TBL] [Abstract][Full Text] [Related]
39. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
Courtney AE; McNamee PT; Nelson WE; Maxwell AP
Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
[TBL] [Abstract][Full Text] [Related]
40. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
Tanaka K; Moriyama T; Iwasaki C; Takei T; Nitta K
Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
